Gene · 4775
Papers1,451
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,451
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| CiLiQuant: Quantification of RNA Junction Reads Based on Their Circular or Linear Transcript Origin. | Front Bioinform | 2022 | 36304262 | PubTator, text mining | PubMed |
| A Single Nucleotide Polymorphism (rs3811792) Affecting Human SCD5 Promoter Activity Is Associated with Diabetes Mellitus. | Genes (Basel) | 2022 | 36292669 | PubTator, text mining | PubMed |
| The SOCE Machinery: An Unbalanced Knowledge between Left and Right Ventricular Pathophysiology. | Cells | 2022 | 36291148 | PubTator, text mining | PubMed |
| Potential of Epidermal Growth Factor-like Peptide from the Sea Cucumber Stichopus horrens to Increase the Growth of Human Cells: In Silico Molecular Docking Approach. | Mar Drugs | 2022 | 36286420 | PubTator, text mining | PubMed |
| Exosomes derived from bone marrow mesenchymal stem cells inhibit human aortic vascular smooth muscle cells calcification via the miR-15a/15b/16/NFATc3/OCN axis. | Biochem Biophys Res Commun | 2022 | 36257194 | PubTator, text mining | PubMed |
| A phenotype-based forward genetic screen identifies Dnajb6 as a sick sinus syndrome gene. | Elife | 2022 | 36255053 | PubTator, text mining | PubMed |
| MYC-mediated silencing of miR-181a-5p promotes pathogenic Th17 responses by modulating AKT3-FOXO3 signaling. | iScience | 2022 | 36248732 | PubTator, text mining | PubMed |
| Transfer RNA-derived small RNAs and their potential roles in the therapeutic heterogeneity of sacubitril/valsartan in heart failure patients after acute myocardial infarction. | Front Cardiovasc Med | 2022 | 36247465 | PubTator, text mining | PubMed |
| Chlorogenic acid for cancer prevention and therapy: Current status on efficacy and mechanisms of action. | Pharmacol Res | 2022 | 36243332 | PubTator, text mining | PubMed |
| miR-140-5p and miR-140-3p: Key Actors in Aging-Related Diseases? | Int J Mol Sci | 2022 | 36232738 | PubTator, text mining | PubMed |
| Distinct roles of ORAI1 in T cell-mediated allergic airway inflammation and immunity to influenza A virus infection. | Sci Adv | 2022 | 36206339 | PubTator, text mining | PubMed |
| Targeted transcript analysis in muscles from patients with genetically diverse congenital myopathies. | Brain Commun | 2022 | 36196089 | PubTator, text mining | PubMed |
| Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. | J Exp Clin Cancer Res | 2022 | 36195959 | PubTator, text mining | PubMed |
| Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes. | PLoS Pathog | 2022 | 36190982 | PubTator, text mining | PubMed |
| The interplay between physical cues and mechanosensitive ion channels in cancer metastasis. | Front Cell Dev Biol | 2022 | 36158191 | PubTator, text mining | PubMed |
| Qingyi decoction attenuates intestinal epithelial cell injury via the calcineurin/nuclear factor of activated T-cells pathway. | World J Gastroenterol | 2022 | 36157544 | PubTator, text mining | PubMed |
| Chaperone-assisted E3 ligase CHIP: A double agent in cancer. | Genes Dis | 2022 | 36157498 | PubTator, text mining | PubMed |
| Circular RNAs Involved in the Regulation of the Age-Related Pathways. | Int J Mol Sci | 2022 | 36142352 | PubTator, text mining | PubMed |
| Cav2.2-NFAT2-USP43 axis promotes invadopodia formation and breast cancer metastasis through cortactin stabilization. | Cell Death Dis | 2022 | 36137995 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4775/papers?page=12